Kevin Gardner Wins Award for the Biophysics of Health and Disease
He is recognized for advancing disease pathogenesis and treatment.
This month, the Biophysical Society named Professor Kevin Gardner (GC/City College, Biochemistry, Biology, Chemistry) recipient of the 2023 Award for the Biophysics of Health and Disease. The award recognizes significant contributions to understanding the fundamental cause or pathogenesis of disease, and enabling treatment or prevention.
Gardner, who directs the Structural Biology Initiative at the Advanced Science Research Center at the Graduate Center (CUNY ASRC), was honored for his development and application of magnetic resonance methodology to understand the regulation mechanism of molecular switches. This led to the development of the cancer drug belzutifan, also known by the brand name Welireg, approved by the U.S. Food and Drug Administration last year.